Harold E Selick's Net Worth
$1.15 Million
Who is Harold E Selick?
Harold E Selick has an estimated net worth of $1.15 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, CATALYST BIOSCIENCES, INC., Molecular Templates, Inc., and PDL BIOPHARMA, INC..
SEC CIK
Harold E Selick's CIK is 0001287233
Past Insider Trading and Trends
2014 was Harold E Selick's most active year for acquiring shares with 9 total transactions. Harold E Selick's most active month to acquire stocks was the month of April. 2018 was Harold E Selick's most active year for disposing of shares, totalling 5 transactions. Harold E Selick's most active month to dispose stocks was the month of December. 2019 saw Harold E Selick paying a total of $382,486.10 for 156,360 shares, this is the most they've acquired in one year. In 2008 Harold E Selick cashed out on 49,019 shares for a total of $99,998.76, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $25.52
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.18% | 6.49K |
$1.89 | $12,266.10 | 28K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +40.47% | 6.2K |
$0.87 | $5,390.52 | 21.51K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
| +362.54% | 12K |
$6.70 | $80,400.00 | 15.31K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 3.31K |
$1.31 | $4,336.10 | 3.31K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CATALYST BIOSCIENCES, INC. (GYRE) Snapshot price: $11.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
| +102.35% | 16.61K |
—
|
—
| 32.85K |
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Molecular Templates, Inc. (MTEM) Snapshot price: $3.59
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
| +5.07% | 20.94K |
$2.05 | $42,931.10 | 433.87K |
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
| +5.10% | 19.61K |
$1.86 | $36,469.02 | 403.93K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
| -4.81% | -18.00K |
—
|
—
| 355.84K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +14.67% | 47.62K |
$2.10 | $99,999.90 | 372.32K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +20.11% | 52.36K |
$1.86 | $97,382.16 | 312.67K |
Oct 5
| |||
Form 4
| +8.34% | 20K |
$1.52 | $30,300.00 | 259.9K |
Jun 3 - Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4/A
| +25.74% | 49.02K |
$2.04 | $99,998.76 | 239.48K |
Aug 29
| |||
Form 4
| -16.99% | -49.02K |
$2.04 | -$99,998.76 | 239.48K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
| +0.31% | 3.48K |
$0.56 | $1,951.04 | 1.14M |
Nov 29
| |||
Form 4
| +0.03% | 300 |
$0.56 | $168.00 | 1.13M |
Nov 21
| |||
Form 4
| +1.18% | 13.22K |
$0.58 | $7,665.28 | 1.13M |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 26 - Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 27 - Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
| 85.96K |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDL BIOPHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +26.84% | 54.35K |
$2.76 | $150,000.48 | 256.83K |
Jun 8
| |||
Form 4
| +42.84% | 60.73K |
$2.47 | $150,000.63 | 202.48K |
Jun 9
| |||
Form 4
| +100.42% | 71.02K |
$3.52 | $250,000.96 | 141.75K |
Jun 2
| |||
Form 4
| +45.32% | 22.06K |
$6.80 | $150,001.20 | 70.73K |
May 28
| |||
Form 4
| +14.06% | 6K |
$8.08 | $48,486.90 | 48.67K |
Nov 26
| |||
Form 4
| +14.40% | 5.37K |
$9.31 | $50,004.01 | 42.67K |
May 28
| |||
Form 4
| +19.07% | 5.97K |
$8.37 | $50,002.38 | 37.3K |
May 21
| |||
Form 4
| +33.86% | 7.92K |
$6.31 | $50,000.44 | 31.32K |
Jun 5
| |||
Form 4
| +56.93% | 8.49K |
$5.89 | $50,000.21 | 23.4K |
Jun 22
| |||
Form 4
| +197.57% | 9.9K |
$5.05 | $49,995.00 | 14.91K |
Jun 9
| |||
Form 4
|
∞
| 5.01K |
$8.42 | $42,192.62 | 5.01K |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||